DOI QR코드

DOI QR Code

A Case Report of the Hemostatic Effect of Samchilgeun Powder (Panax Motoginseng) on Hematuria in a Patient Requiring Double Antiplatelet Therapy Due to Recurrent Cerebral Infarction

재발된 뇌경색으로 이중항혈소판요법 필수인 환자의 혈뇨에 대한 삼칠근말의 지혈효과 증례보고 1례

  • Kim, Seo-hyun (Dept. of Cardiovascular and Neurologic Diseases of Korean Internal Medicine, Daegu Korean Medicine Hospital of Daegu Haany University) ;
  • Kang, Ji-hyeon (Dept. of Cardiovascular and Neurologic Diseases of Korean Internal Medicine, Daegu Korean Medicine Hospital of Daegu Haany University) ;
  • Kim, Jun-seok (Dept. of Cardiovascular and Neurologic Diseases of Korean Internal Medicine, Daegu Korean Medicine Hospital of Daegu Haany University) ;
  • Jang, Woo-seok (Dept. of Cardiovascular and Neurologic Diseases of Korean Internal Medicine, Daegu Korean Medicine Hospital of Daegu Haany University)
  • 김서현 (대구한의대학교 부속 대구한방병원 심계내과교실) ;
  • 강지현 (대구한의대학교 부속 대구한방병원 심계내과교실) ;
  • 김준석 (대구한의대학교 부속 대구한방병원 심계내과교실) ;
  • 장우석 (대구한의대학교 부속 대구한방병원 심계내과교실)
  • Received : 2022.09.15
  • Accepted : 2022.10.26
  • Published : 2022.10.30

Abstract

Objective: The purpose of this study was to investigate the effect of Samchilgeun powder (panax notoginseng) on the treatment of hematuria in a patient requiring double antiplatelet therapy due to recurrent cerebral infarction. Methods: The patient was treated with Samchilgeun powder (panax notoginseng) combined with Western medicine (an antiplatelet). Urinalysis was performed to observe hematuria and proteinuria levels, and blood tests were used to evaluate anemia levels. Results: After treatment, hematuria levels decreased without exacerbation of anemia and proteinuria and even recurrence of cerebral infarction. Conclusions: This study suggests that Samchilgeun powder (panax notoginseng) can effectively treat patients with hematuria requiring double antiplatelet therapy due to recurrent cerebral infarction, but further studies should be conducted.

Keywords

References

  1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324(7329):71-86. https://doi.org/10.1136/bmj.324.7329.71
  2. Korean Neurological Association. Neurology. 3rd rev. Seoul: Panmun; 2017, p. 673.
  3. Khadra MH, Pickard RS, Charlton M, Powell PH, Neal DE. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol 2000;163(2):524-7. https://doi.org/10.1016/S0022-5347(05)67916-5
  4. Kim HJ, Choi HY, Kim KI, Kim HJ, Chang JH, Kim HW, et al. Clinical Significance of Renal Biopsy in Adults with Asymptomatic Microscopic Hematuria. Korean Journal of Nephrology 2003; 22(6):684-91.
  5. Shin GT, Lee HM, Kim SJ, MA KA, Ji SB, Kim SD, et al. Cystoscopy in the Evaluation of Hematuria. Korean Journal of Nephrology 1999;18(1):128-33.
  6. 정석원. 항혈소판제 및 항응고제 사용 환자에서의 위장관내시경. 대한내과학회 2017;2017(2):1-4.
  7. Hwang JW, Go JE, Go HY, Choi YK, Park JH, Jun CY. Influence of Five Herbal Medicines on Cytochrome P450 3A4 Drug-Metabolizing Enzymes in Human Liver Microsomes. J Int Korean Med 2008;29(4):846-55.
  8. Kim IR, Kim HC, Park SJ, Park JH, Seo BI, Seo YB, et al. Bonchohak. Seoul: Yeongnimsa; 2004, p. 440-1.
  9. Lau AJ, Toh DF, Chua TK, Pang YK, Woo SO, Koh HL. Antiplatelet and anticoagulant effects of Panax notoginseng: Comparison of raw and steamed Panax notoginseng with Panax ginseng and Panax quinquefolium. J Ethnopharmacol 2009;125(3):380-6. https://doi.org/10.1016/j.jep.2009.07.038
  10. Lee SY. Diagnostic Approach to Hematuria. Korean J Med 2010;79(1):8-10.
  11. Chaudhri I, Moffitt R, Taub E, Annadi RR, Hoai M, Bolotova O, et al. Association of Proteinuria and Hematuria with Acute Kidney Injury and Mortality in Hospitalized Patients with COVID-19. Kidney Blood Press Res 2020; 45(6):1018-32. https://doi.org/10.1159/000511946
  12. Cho HJ, Kang TH. Pharmacological Secondary Prevention of Ischemic Stroke. Brain Neurorehabil 2014;7(2):76-85. https://doi.org/10.12786/bn.2014.7.2.76
  13. Whalen K. Lippincott's Illustrated Review: Pharmacology. 6th Edition. Seoul: Shinilbooks; 2015, p. 298.
  14. Yamagata K, Takahashi H, Tomida C, Yamagata Y, Koyama A. Prognosis of asymptomatic hematuria and/or proteinuria in men. High prevalence of IgA nephropathy among proteinuric patients found in mass screening. Nephron 2002;91(1) :34-42. https://doi.org/10.1159/000057602
  15. Ebrahimi F, Torbati M, Mahmoudi J, Valizadeh H. Medicinal Plants as Potential Hemostatic Agents. J Pharm Pharm Sci 2020;23(1):10-23. https://doi.org/10.18433/jpps30446
  16. Jeon WK, Kim HK, Lee JH, Ko BS, Lee AY, Lee KG, et al. Study on Anti-thrombotic Activities of KIOM2003-080. Korean Journal of Oriental Medicine 2007;13(2):143-8.
  17. White CM, Fan C, Song J, Tsikouris JP, Chow M. An evaluation of the hemostatic effects of hydrophilic, alcohol, and lipophilic extracts of notoginseng. Pharmacotherapy 2001;21(7):773-7. https://doi.org/10.1592/phco.21.9.773.34561
  18. Liang W, Leung PC, Yew DT. Panax notoginseng: A Double-Edged Sword in Haemostasis? Altern Integr Med 2013;2(9):e100.
  19. Dong TTX, Cui XM, Song ZH, Zhao KJ, Ji ZN, Lo CK, et al. Chemical assessment of roots of Panax notoginseng in China: regional and seasonal variations in its active constituents. J Agric Food Chem 2003;51(16):4617-23. https://doi.org/10.1021/jf034229k
  20. Jeon HJ, Park SR, Lee SK. Improvement of Chronic Bleeding in the Patient with Unresectable Advanced Gastric Cancer Using the Decoction of Notoginseng Radix - a Case Report. J Korean Med 2016;37(2):104-9. https://doi.org/10.13048/jkm.16026
  21. Wang SY, Tao T, Hu HY, Yuan JY, Zhao L, Sun BY, et al. Effects of initiating time and dosage of Panax notoginseng on mucosal microvascular injury in experimental colitis. World J Gastroenterol 2017:23(47):8308-20. https://doi.org/10.3748/wjg.v23.i47.8308